Tag : headache (migraine)

Neurology

Fremanezumab May Reduce Attacks in Tough-to-Treat Migraine

Newsemia
The CGRP-targeting migraine-prevention drug fremanezumab is safe and effective in reducing migraines for patients who have failed up to four other therapies, new research shows....
Neurology

Galcanezumab Cuts Frequency of Disabling Cluster Headaches

Newsemia
Galcanezumab is a welcome option for patients who have grown frustrated with currently available treatment options, one headache expert said. Medscape Medical News Source link...
Neurology

What's Hot at AAN 2019?

Newsemia
‘Philly Spectacular’ is the theme of this year’s AAN Annual Meeting, says the event’s science committee chair, adding that more than 15,000 attendees are expected...
Neurology

Type 2 Diabetes Risk May Be Lower in Women With Migraine

Newsemia
Dr Laurie Barclay on the future implications of this analysis of data from a large French prospective population-based study. Medscape Neurology Source link...
Neurology

Neuromodulation Devices in Migraine: The Latest

Newsemia
Dr Jessica Ailani provides an update on neuromodulation devices for the acute and preventive treatment of migraines. American Headache Society and Medscape Source link...
Neurology

AHS Releases Updated Guidance on Migraine Treatment

Newsemia
In response to recent advances in drug and device technology for treating migraine, the American Headache Society (AHS) has released new guidance on best preventive...
Neurology

'Brain Tsunami': Spreading Depolarization After SAH

Newsemia
Researchers have discovered a new mechanism that contributes to cell death after a subarachnoid hemorrhage (SAH), providing a new target for therapeutic intervention. Medscape Medical...
Neurology

The Year in Neurology 2018

Newsemia
New studies in 2018: Dr Hans-Christoph Diener discusses recent results from studies across neurology that have led to practice changes. Medscape Neurology Source link...
Neurology

Anti-CGRP Monoclonal Antibodies for Migraine Prevention

Newsemia
Dr Deborah Friedman reviews the new anti-CGRP monoclonal antibodies for migraine prevention. American Headache Society and Medscape Source link...
Neurology

FDA Greenlights Galcanezumab (Emgality) for Migraine Prevention

Newsemia
On the heels of recent approvals for two other calcitonin gene-related peptide (CGRP) antagonists for the prevention of migraine in adults, the FDA has approved...
Neurology

FDA Clears Brain Stimulation Device for OCD

Newsemia
The Brainsway deep transcranial magnetic stimulation system is an option for patients with obsessive-compulsive disorder (OCD) who have not responded to traditional treatments. FDA Approvals...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy